Maravai LifeSciences Holdings, Inc. (MRVI)

7.68 -8.24% (-0.69)

Over 1Y: +222.7%

2026-08-28
Style
Area Line Line with markers Steps Candlesneeds a shorter window Hollow candlesneeds a shorter window Barsneeds a shorter window

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

2 4 6 8
Aug Oct Dec Feb Apr Jun Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '25 — Revenue: 41.6M Q3 '25 — Operating Cash Flow: -15.2M Q3 '25 — Free Cash Flow: -18.8M Q3 '25 — Net Income: -25.6M Q4 '25 — Revenue: 49.9M Q4 '25 — Operating Cash Flow: -22.8M Q4 '25 — Free Cash Flow: -24.9M Q4 '25 — Net Income: -35.7M Q1 '26 — Revenue: 65.8M Q1 '26 — Operating Cash Flow: 8.7M Q1 '26 — Free Cash Flow: 4.2M Q1 '26 — Net Income: -3.7M Q2 '26 — Revenue: 51.4M Q2 '26 — Operating Cash Flow: 4M Q2 '26 — Free Cash Flow: 3.6M Q2 '26 — Net Income: -12.4M -25M 0 25M 50M 75M
Q3 '25 Q4 '25 Q1 '26 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

1.4
SBC / sales 14.3%
OE margin -31.5%
Oper. margin -56.1%
ROIC -29.5%
Accruals -8.6%
Gross margin 34.9%
EBITDA margin -45.5%
FCF margin -17.2%
OCF margin -12.1%
Profit margin -37.1%
ROA -12.8%
ROCE -20.7%
ROE -37.8%
OCF / EBIT —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.1
RPO / sales 0.0095×
Segment HHI 0.54 HHI
RPO growth —

4 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

4.2
ND/EBITDA —
Quick ratio 3.0×
Cash / Debt 0.39×
Net debt / Eq 0.53×
Debt / Eq 0.87×
F-score 1.0 pts
Cash runway —
Debt payback —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

2.6
Sales CAGR 4Y -30.6%
Sales/sh Y/Y -9.3%
Sales Q/Q +8.5%
Div. growth -94.9%
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.